Strategic Development of Neural Stem & Progenitor Cell Products - 2014 Update

DUBLIN, January 28, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/6l52c9/strategic) has announced the addition of the "Strategic Development of Neural Stem & Progenitor Cell Products - 2014 Update" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.

The terms neuronal and neural also need to be defined. Technically speaking, neuronal means pertaining to neurons," and neural means pertaining to nerves, which are the cordlike bundles of fibers made up of neurons. Since both terms ultimately are descriptive of neurons, the scientific community uses the terms "neuronal" and "neural" interchangeably. The complexity of this issue is explored from a strategic perspective within this report.

In particular, when naming products, companies are advised to use the term neural rather than neuronal, both in reference to stem cells and progenitor cells, in order to best position products within the marketplace. Also of interest is that when stem cell versus progenitor cell publications are compared, neural/neuronal stem cell publication rates continue to outpace neural/neuronal progenitor cell publications by over 200% over a trailing two-year period.


Key Topics Covered: 

I. BACKGROUND
A. Language and Definitions
B. Brief History
C. Regulation of Neural Stem & Progenitor Cells
D. Product Background

II. APPLICATIONS
A. Basic Research
B. Drug Discovery Applications
C. Drug Delivery Applications
D. Neural Toxicology Assessment
E. Neural Transplantation
F. Brain Tumor Research

III. APPLICATION PRIORITIES
A. Overall
B. Breakdown of Neural Stem Cell Research by Disorder
C. By Segment

IV. PATENTS
A. Key Neural Stem and Progenitor Cell Patents
B. Additional US Patents
C Additional European Patents

V. MARKET TREND ANALYSIS
A. Clinical Trial Analysis
B. Grant Rate Analysis
C. Patent Rate Analysis
D. Scientific Publication Rate Analysis
E. Geographical Analysis: Domestic vs. International Status

VI. MARKET SIZE
A. Definition: NSC Product Market
B. Experimental Approach
C. NSC Research Products
D. NSC Therapy Market

VII. COMPETITORS: LEADING SUPPLIERS OF NEURAL STEM CELL PRODUCTS
A. EMD Millipore
B. STEMCELL Technologies
C. AlphaGenix, Inc. 
D. R&D Systems
E. Cell Applications
F. SA Biosciences
G. ScienCell
H. Neuromics
I. Amaxa
J. Life Technologies
K. Sigma Aldrich 
L. StemCells, Inc.
M. Lonza
N. BD Biosciences

VIII. LEADING PHARMACEUTICAL COMPANIES DEVELOPING NEURAL STEM CELL THERAPIES
A. Neuralstem, Inc
B. NeuroNova AB
C. NeuroGeneration

IX. BREAKDOWN OF STEM CELL RESEARCH ACTIVITY BY CELL TYPE

X. POTENTIAL END-USERS OF NEURAL STEM CELL PRODUCTS
A. Academic Labs
B. Private Labs
C. Commercial Labs
D. Government Labs

XI. PRODUCT IDEAS & SUGGESTIONS
A. Product Categories
B. Product Suggestions
4. NSCs Derived from Novel Sources
5. Novelty Cells Types, such as Neural Rosette Cells (R-NSCs)

XII. SCIENTIST PANEL: DETAILED END-USER SURVEY

A. Survey Overview
B. Characterization of Market Survey Respondents
C. Survey Findings
D. Terms Used in Online Product Search

XIII. CONCLUSIONS 

For more information visit http://www.researchandmarkets.com/research/6l52c9/strategic

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net